Stroke Outcomes Worse After Endovascular Thrombectomy, BP Variability
Similar outcomes have been documented in treatment with IV tPA with BP variability.
Similar outcomes have been documented in treatment with IV tPA with BP variability.
Short-term memory and levels of fatigue improved, but no benefit for depression was observed.
Those treated with DBS had a 50% lower risk of worsening motor symptoms compared to those on drug therapy alone.
Risk appeared to be correlated with RLS disease duration.
As many as 50% of neurotoxic chemotherapy patients experience CPN.
Those with the lowest B12 levels performed worse on cognitive and motor outcomes.
The drug helped to significantly improve social functioning, medication effects, and seizure worry in patients.
Cerebral microbleeds are a marker of vascular burden and should be aggressively pursued with treatment and preventive care.
The disorders react similarly to basal ganglia deep brain stimulation.